Martin Landray, Protas CEO (Illustration: Assistant Editor Kathy Wong for Endpoints News)
Martin Landray knows what controversy in clinical drug development feels like, from first-hand experience.
Landray was the chief architect of RECOVERY, a study that pitted …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
